These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11738761)

  • 1. A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection.
    Martina BE; Airikkala MI; Harder TC; van Amerongen G; Osterhaus AD
    Vaccine; 2001 Dec; 20(5-6):943-8. PubMed ID: 11738761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1.
    Martina BE; van de Bildt MW; Kuiken T; van Amerongen G; Osterhaus AD
    Vaccine; 2003 Jun; 21(19-20):2433-40. PubMed ID: 12744876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major immunogenic proteins of phocid herpes-viruses and their relationships to proteins of canine and feline herpesviruses.
    Harder TC; Harder M; de Swart RL; Osterhaus AD; Liess B
    Vet Q; 1998 Apr; 20(2):50-5. PubMed ID: 9563160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immunological characterization of type-specific and conserved B-cell epitopes of pinniped, felid and canid herpesviruses.
    Lebich M; Harder TC; Frey HR; Visser IK; Osterhaus AD; Liess B
    Arch Virol; 1994; 136(3-4):335-47. PubMed ID: 7518225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.
    Lappin MR; Andrews J; Simpson D; Jensen WA
    J Am Vet Med Assoc; 2002 Jan; 220(1):38-42. PubMed ID: 12680445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic survey for phocid herpesvirus-1 and -2 in marine mammals from Alaska and Russia.
    Zarnke RL; Harder TC; Vos HW; Ver Hoef JM; Osterhaus AD
    J Wildl Dis; 1997 Jul; 33(3):459-65. PubMed ID: 9249690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simplified identification and differentiation of feline, canine and phocine herpesvirus isolates using monoclonal antibodies].
    Harder TC; Lebich M; Liess B
    Tierarztl Prax; 1994 Oct; 22(5):408-12. PubMed ID: 7855845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seal gammaherpesviruses: identification, characterisation and epidemiology.
    Martina BE; Verjans GM; Harder TC; Kuiken T; van de Bildt MW; van Bergen PA; Osterhaus AD
    Virus Res; 2003 Jul; 94(1):25-31. PubMed ID: 12837554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of cats for feline rhinotracheitis results in a quantitative reduction of virulent feline herpesvirus-1 latency load after challenge.
    Sussman MD; Maes RK; Kruger JM
    Virology; 1997 Feb; 228(2):379-82. PubMed ID: 9123845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related disease in recurrent outbreak of phocid herpesvirus type-1 infections in a seal rehabilitation centre: evaluation of diagnostic methods.
    Harder TC; Vos H; de Swart RL; Osterhaus AD
    Vet Rec; 1997 May; 140(19):500-3. PubMed ID: 9172297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteins gl and gE of feline herpesvirus-1 are virulence genes: safety and efficacy of a gl-gE deletion mutant in the natural host.
    Kruger JM; Sussman MD; Maes RK
    Virology; 1996 Jun; 220(2):299-308. PubMed ID: 8661381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modified live or inactivated feline herpesvirus-1 parenteral vaccines on clinical and laboratory findings following viral challenge.
    Summers SC; Ruch-Gallie R; Hawley JR; Lappin MR
    J Feline Med Surg; 2017 Aug; 19(8):824-830. PubMed ID: 27432436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of phocid herpesvirus-1 and -2 as putative alpha- and gammaherpesviruses of North American and European pinnipeds.
    Harder TC; Harder M; Vos H; Kulonen K; Kennedy-Stoskopf S; Liess B; Appel MJ; Osterhaus AD
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():27-35. PubMed ID: 8558126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
    Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
    Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo replication of seal gammaherpesviruses in cells of multiple species.
    Martina BE; Verjans GM; Kuiken T; van Amerongen G; Osterhaus AD
    Microbes Infect; 2007 Jan; 9(1):40-6. PubMed ID: 17194610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1.
    Lappin MR; Sebring RW; Porter M; Radecki SJ; Veir J
    J Feline Med Surg; 2006 Jun; 8(3):158-63. PubMed ID: 16442823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to feline herpesvirus-1 vaccination in healthy adult cats.
    Bergmann M; Speck S; Rieger A; Truyen U; Hartmann K
    J Feline Med Surg; 2020 Apr; 22(4):329-338. PubMed ID: 31079527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1.
    Visser IK; Vedder EJ; van de Bildt MW; Orvell C; Barrett T; Osterhaus AD
    Vaccine; 1992; 10(7):435-8. PubMed ID: 1609546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.